Topic: Scott Johnson

8 chapters across the catalog

Rolling Start
Episode 1603 25:46 - 33:57

1603: Rolling Start

Mike Johnson Speaker Election, Secularist Criticism

Pundits Scott Galloway and Kara Swisher expressed significant alarm over the election of Mike Johnson as Speaker of the House, labeling him "David Duke Light." Their criticism focuses on Johnson's devout Christian faith and his previous legal work for the Alliance Defending Freedom. The discussion highlights a growing fear among secularists regarding the influence of "white Christian nationalism" in the federal government.

Immunity Debt
Episode 1367 18:07 - 20:34

1367: Immunity Debt

Anthony Fauci and Scott Gottlieb on Vaccine Boosters

Dr. Anthony Fauci and Pfizer board member Dr. Scott Gottlieb offered conflicting perspectives on the necessity of COVID-19 booster shots. While Pfizer advocates for a third dose to combat waning immunity in the elderly, Fauci stated there is currently no indication that Johnson & Johnson recipients require a booster. The debate highlights potential friction between pharmaceutical marketing strategies and federal health agency recommendations.

Pingdemic
Episode 1366 1:05:22 - 1:07:32

1366: Pingdemic

J&J Efficacy and the Push for Boosters

A New York University study suggests the Johnson & Johnson vaccine is only 33% effective against the Delta variant, contradicting the company's own data. Former FDA Commissioner Scott Gottlieb stated on MSNBC that COVID-19 vaccinations may become an annual requirement. The number "33" is highlighted as a potential signal for the start of a coordinated booster shot campaign.

Stilts and Steroids
Episode 1355 15:14 - 23:03

1355: Stilts and Steroids

Scott Gottlieb Pfizer Board Role, CNBC Vaccine Safety Coverage

Former FDA Commissioner and current Pfizer board member Scott Gottlieb appeared on CNBC to discuss heart inflammation "clusters" in vaccinated individuals aged 6 to 24. Critics argue his commentary protects Pfizer's interests while being more critical of competitors like Johnson & Johnson. Despite official claims that adverse events are rare and mild, VAERS data shows over 1,000 cases of myocarditis and thousands of severe allergic reactions.

Bunny Hugging
Episode 1341 5:27 - 10:02

1341: Bunny Hugging

Vaccine Hesitancy and Johnson & Johnson Pause

The hosts analyze the decline in vaccination rates following the temporary market removal of the Johnson & Johnson vaccine. They argue that government messaging claiming all vaccines are the same caused the public to lose confidence in Pfizer and Moderna as well. A news gaffe where a reporter said "euthanized" instead of "immunized" is highlighted as a symbolic error.

Pre-Decisional
Episode 1260 28:30 - 32:18

1260: Pre-Decisional

Mask Efficacy, Carbon Dioxide Concerns

Dr. Scott Johnson discussed the technical limitations of masks, noting that N95 filters are designed for 0.3 microns while virus particles are 0.1 microns. Personal anecdotes also highlighted the potential for dizziness and carbon dioxide buildup during prolonged mask use, particularly in high-heat environments like Florida.

The Angries
Episode 877 2:09:22 - 2:13:52

877: The Angries

CNN's 24 Reasons for Hillary Clinton's Loss

The hosts review a CNN list of 24 reasons why Hillary Clinton lost, which includes factors like fake news on Facebook, low voter turnout, and the "coastal elite" shaming of Trump supporters. They mock the contradictory inclusion of both "not because of Comey" and "because of Comey" on the same list.

We Live!!!
Episode 306 8:51 - 18:06

306: We Live!!!

Unabomber Ted Kaczynski, Tylenol Murders, DNA Testing

The FBI is seeking a DNA sample from Ted Kaczynski, known as the Unabomber, to investigate a potential link to the 1982 Tylenol cyanide poisonings. Author Scott Bartz, a former Johnson & Johnson employee, suggests in his upcoming book "The Tylenol Mafia" that the tampering occurred within the company's distribution chain rather than at retail locations. Speculation exists that the FBI's focus on Kaczynski serves as a media distraction to protect pharmaceutical advertisers from liability.